Vigabatrin for Treatment of Cocaine Dependence

NCT00611130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Cocaine Dependence

Interventions

DRUG: vigabatrin
DRUG: placebo

Sponsor

Catalyst Pharmaceuticals, Inc.